BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06253494-completion@plaintrial.com
DTSTAMP:20261027T192734Z
DTSTART;VALUE=DATE:20281231
SUMMARY:Pembrolizumab\, Lenvatinib and IL-15 Superagonist N-803 in Combinat
 ion With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Pa
 rticipants With Advanced or Metastatic Endometrial Cancer — estimated co
 mpletion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06253494
URL:https://plaintrial.com/trial/NCT06253494
END:VEVENT
END:VCALENDAR